Takeda Layoffs 2024 San Diego 2024. Astrazeneca targets $80 billion in revenue by 2030, layoffs at bayer, bms and pfizer continue to generate attention across the biopharma industry, takeda takes a deep dive. Takeda culls cancer, gut and inflammation drugs in r&d rethink.
Not surprising tbh, takeda has a ridiculously large headcount for the amount. The layoffs, part of a broader restructuring by the global company,.
At Its Investor Day 2024.
Takeda is shuttering its san diego research site, the company.
Not Surprising Tbh, Takeda Has A Ridiculously Large Headcount For The Amount.
Japan’s takeda pharmaceutical announced a restructuring on thursday after annual profit slid by more than half following the loss of patent protection of major sellers.
The Company's Workforce Reduction Also Follows Its First Quarter Earnings Results In Which It Generated $172.7 Million In Revenue, Missing The Zacks Consensus Estimate Of $173.